Rezvilutamide: clinical trials recruiting now

Phase breakdown

Conditions being studied

Recruiting trials involving Rezvilutamide

• A Clinical Study of SHR-4394 in Combination With Anti-tumor Therapy in Prostate Cancer
  NCT07407283 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 85 Years · Sex: Male · 2 locations
• Comparing the Efficacy and Safety of Rezvilutamide+ADT+Docetaxel Versus Rezvilutamide +ADT in the mHSPC
  NCT05983783 · Phase: Phase 3 · Ages: 40 Years to 80 Years · Sex: Male · 1 location
• Genomic Biomarker-guided Neoadjuvant Therapy for Prostate Cancer (SEGNO)
  NCT06387056 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
• Neoadjuvant Intense Endocrine Therapy for High Risk and Locally Advanced Prostate Cancer
  NCT05406999 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: Male · 1 location
• Rezvilutamide in Patients With Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer
  NCT05753566 · Phase: Phase 2 · Ages: 40 Years and older · Sex: Male · 2 locations
• Salvage Radiotherapy Combined With Androgen Deprivation Therapy (ADT) With or Without Rezvilutamide in the Treatment of Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer
  NCT06305832 · Phase: Phase 2 · Ages: 40 Years and older · Sex: Male · 2 locations

Common questions

How many recruiting trials involve Rezvilutamide?

6 recruiting trials across 10 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.